MV-003 Dysbiosis

Indicaton

Dysbiosis

ApyraMed promotes microbiome recovery and selection of beneficial bacteria after antibiotic treatment. This results in powerful control of antibiotic-induced enteric infections and metabolic alterations.

Therapeutic indications

Type of product

Other biologics

Table

Phase

Discovery
Partnering status

Not partnered
Available in

World-Wide

You may also be interested in

Avacopan

ANCA - associated vasculitis and C3 gomerulopathy

Filing

MY010

Human antibody product against major birch allergens to treat pollen allergy via
passive immunization.

Discovery

MY006

Human antibody product against major peanut allergens to treat peanut allergy via
passive immunization. In contrast to active immunotherapy, passive immunization
circumvents allergen exposure, making it a safe treatment option for patients with
strong allergies.

Discovery